Recent Advances in Treating Ovarian Cancer
New imaging system can help surgeons get more cancer out; Presurgery chemo can make ovarian cancer responsive to immunotherapy...
Category: Research
New imaging system can help surgeons get more cancer out; Presurgery chemo can make ovarian cancer responsive to immunotherapy...
As more people are surviving cancer, there’s growing concern about how to care for their needs and improve long-term...
On June 1, the U.S. Food and Drug Administration (FDA) approved a liquid biopsy test, a companion diagnostic test...
As a physician-scientist specializing in melanoma, Yvonne Saenger, MD, applies her frequent interactions with patients to her research and...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of cancer types for which immunotherapeutics known...
Late last week, the U.S. Food and Drug Administration (FDA) added another antiangiogenic therapeutic to the armamentarium for oncologists...
We observe May as National Cancer Research Month to celebrate the tremendous advances that have been made in our...
The U.S. Food and Drug Administration (FDA) recently approved the use of molecularly targeted therapeutic afatinib (Gilotrif) for treating...
On April 19, Sven Bilke, PhD, staff scientist in the Genetics Branch of the National Cancer Institute, discussed his...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the antiangiogenic...